The Earth Times Online Newspaper (Free subscription) | 4 hours ago
SAN DIEGO - Sequenom, Inc. (NASDAQ:SQNM), a leading provider of genetic analysis solutions, today announced the purchase by the W.M. Keck Foundation Biotechnology Resource Laboratory at Yale University of Sequenom's MassARRAY
Medical,Health News and Articles (Free subscription) | 6 hours ago
Scientists funded by the Biotechnology and Biological Sciences Research Council (BBSRC) have found a fast and effective way to investigate important aspects of human aging. Working at the University of Oxford and The Open University, Dr Lynne Cox and Dr Robert Saunders have discovered a gene in fruit flies that means flies can now be [...]
Seattle Times (Free subscription) | 9 hours ago
After months of searching for a suitable chief executive, local biotechnology startup Fate Therapeutics has found its match in Southern...
Law Blog - WSJ.com (Free subscription) | 14 hours ago
Takeda Pharmaceutical posted a 5.9% rise in full-year net profit, but said it expects earnings to slump in the current year following its recent $8.8 billion purchase of a U.S. biotechnology company.
P2P Foundation (Free subscription) | yesterday
An announcement from Steve Talbott, whose thoughtful approach I have always appreciated: “The University Press of Kentucky has this month released a new book that Nature Institute co-founder Craig Holdrege and I have co-authored: * Beyond Biotechnology: The Barren Promise of Genetic Engineering*. The book is part of the new “Culture of the Land” series launched by [...]
Biotech Blog (Free subscription) | yesterday
The science of biotechnology is tough. R&D can be unpredictable, and most products need regulatory approval before they can be sold. But biotechnology companies also need to worry about other problems, like management issues. The case of Dyadic's illustrates some of the often-overlooked challenges in commercializing biotechnology. Mark Emalfarb founded Dyadic in 1979 as a supplier...
Deseret Morning News (Free subscription) | yesterday
Science has provided the souped-up seeds to feed the world, through biotechnology and old-fashioned crossbreeding. Now the problem is the dirt they're planted in.
ETF Trends (Free subscription) | 05/10/2008
Biotechnology is rising up to analyst's predictions that a near future run could send related stocks and exchange traded funds (ETFs) up. The latest April announcement that Takeda Pharmaceutical would buy Massachusetts-based Millennium Pharmaceuticals (MLMN) for $8.8 billion sent the...
The Futurist (Free subscription) | 05/10/2008
Popular Mechanics has assembled one of those captivating lists of new technologies that will improve our lives, this time on healthcare technologies (via Instapundit). Just a few years ago, these would have appeared to be works of science fiction. Go...
CBS 4 - South Florida's Source for (Free subscription) | 05/10/2008
Science has provided the souped-up seeds to feed the world, through biotechnology and old-fashioned crossbreeding. Now the problem is the dirt they are planted in.
Mondo Visione (Free subscription) | 05/10/2008
The NASDAQ OMX Group, Inc. ("NASDAQ") (Nasdaq: NDAQ ) announced today the results of the semi-annual re-ranking of the NASDAQ Biotechnology Index(r) (Nasdaq: NBI ), which will become effective with the market open on Monday, May 19, 2008.
Boston Globe (Free subscription) | 05/09/2008
Gov. Deval Patrick, House Speaker Salvatore DiMasi and Senate President Therese Murray are taking a road trip to San Diego next month for a major biotechnology conference. The way things are shaping up, they could end up as the proverbial skunks at a lawn party.
Treehugger (Free subscription) | 05/09/2008
Store Wars! Revolution is in the air, as the Swiss Government's Federal Ethics Committee on Non-Human Biotechnology concludes that plants have rights, and we have to treat them appropriately. A majority of the panel concluded that "living organisms should be considered morally for their own sake because they are alive." The Weekly Standard, which is appalled, gives an example of how a farmer...
WorkAtHome (Free subscription) | 05/09/2008
Gov. Deval Patrick, House Speaker Salvatore DiMasi and Senate President Therese Murray are taking a road trip to San Diego next month for a major biotechnology conference. The way things are shaping up, they could end up as the proverbial skunks at a lawn party.
Medical News Today (Free subscription) | 05/09/2008
The Atlanta-based biotechnology firm GeoVax Labs plans to launch Phase II clinical trials of its experimental HIV vaccine this summer, company officials recently announced, the Atlanta Journal-Constitution reports (Hendrick, Atlanta Journal-Constitution, 5/8).GeoVax while in midstage development of its HIV vaccine candidate enrolled 140 people in four independent national trials.
The 3 the latest comments published by users on Biotechnology :
vedha | 01/18/2008
The Indian biotechnology industry, owing to its small size, was insulated from the boombust cycle. It has been growing at a strong pace in recent years, adding value to pharmaceuticals, agriculture and industry. The revenue of the Indian biotechnology industry reached Rs47450 million in 2004-05, up 36.55% from Rs 34750 million in 2003-04. In 2004- 05, as many as six Indian companies reported revenue...
vedha | 01/17/2008
The global biotech industry was estimated to be USD73.12 billion in 2006 compared to USD63.3 billion in 2005 up by 15.49%. There is an increase in the global revenues from Canada and Europe regions which is the new cynosure for the global industry. The segments of the industry along with the major global players of the industry are also discussed with their profiles. This report also has details on...
nitesh | 01/07/2008
This is to facilitate you with the editable power point presentation on Global Biotechnology Industry. This Power point presentation provides the comprehensive industry Analysis covering areas like - Highlights, Industry Overview, Growth drivers, Issues & challenges, Technology, Major markets, Major players, Regulatory aspects, Mergers & acquisitions, Critical success factors and Future outlook. In...
